Long-Term Improvement in the Patient-Reported Outcomes of Rectal Bleeding, Stool Frequency, and Health-Related Quality of Life with Tofacitinib in the Ulcerative Colitis OCTAVE Clinical Program.
David P HudesmanJoanna TorresLeonardo SaleseJohn C WoolcottRajiv MundayatChinyu SuMahmoud H MosliJessica R AllegrettiPublished in: The patient (2022)
gov (NCT01465763 [21/10/2011]; NCT01458951 [21/10/2011]; NCT01458574 [21/10/2011]; NCT01470612 [21/10/2011]).